Frank McGrew
About
In The Last Decade
Frank McGrew
19 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Cardiology and Cardiovascular Medicine 815
- Pulmonary and Respiratory Medicine 258
- Molecular Biology 177
- Surgery 160
- Nephrology 143
Countries citing papers authored by Frank McGrew
This map shows the geographic impact of Frank McGrew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank McGrew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank McGrew more than expected).
Fields of papers citing papers by Frank McGrew
This network shows the impact of papers produced by Frank McGrew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank McGrew. The network helps show where Frank McGrew may publish in the future.
Co-authorship network of co-authors of Frank McGrew
This figure shows the co-authorship network connecting the top 25 collaborators of Frank McGrew. A scholar is included among the top collaborators of Frank McGrew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank McGrew. Frank McGrew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 45 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 6 | |
| 7 | 2 | |
| 8 | 14 | |
| 9 | Periodontal and cardiovascular diseases: common inflammatory mediators. | 1 |
| 10 | 130 | |
| 11 | 7 | |
| 12 | 4 | |
| 13 | 7 | |
| 14 | ACUTE AND CHRONIC THERAPEUTIC IMPACT OF A VASOPRESSIN ANTAGONIST IN CONGESTIVE HEART FAILURE (ACTIV IN CHF) INVESTIGATORS. EFFECTS OF TOLVAPTAN, A VASOPRESSIN ANTAGONIST, IN PATIENTS HOSPITALIZED WITH WORSENING HEART FAILURE: A RANDOMIZED CONTROLLED TRIAL | 113 |
| 15 | 168 | |
| 16 | 143 | |
| 17 | 31 | |
| 18 | 448 | |
| 19 | 19 | |
| 20 | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.